Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C12H12FN5O3 |
| Molecular Weight | 293.2538 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=C2N=CN([C@H]3C[C@H](O)[C@@](CO)(O3)C#C)C2=NC(F)=N1
InChI
InChIKey=IKKXOSBHLYMWAE-QRPMWFLTSA-N
InChI=1S/C12H12FN5O3/c1-2-12(4-19)6(20)3-7(21-12)18-5-15-8-9(14)16-11(13)17-10(8)18/h1,5-7,19-20H,3-4H2,(H2,14,16,17)/t6-,7+,12+/m0/s1
| Molecular Formula | C12H12FN5O3 |
| Molecular Weight | 293.2538 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:11:50 GMT 2023
by
admin
on
Sat Dec 16 10:11:50 GMT 2023
|
| Record UNII |
QPQ082R25D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6483431
Created by
admin on Sat Dec 16 10:11:50 GMT 2023 , Edited by admin on Sat Dec 16 10:11:50 GMT 2023
|
PRIMARY | |||
|
QPQ082R25D
Created by
admin on Sat Dec 16 10:11:50 GMT 2023 , Edited by admin on Sat Dec 16 10:11:50 GMT 2023
|
PRIMARY | |||
|
865363-93-5
Created by
admin on Sat Dec 16 10:11:50 GMT 2023 , Edited by admin on Sat Dec 16 10:11:50 GMT 2023
|
PRIMARY | |||
|
10890
Created by
admin on Sat Dec 16 10:11:50 GMT 2023 , Edited by admin on Sat Dec 16 10:11:50 GMT 2023
|
PRIMARY | |||
|
DB15653
Created by
admin on Sat Dec 16 10:11:50 GMT 2023 , Edited by admin on Sat Dec 16 10:11:50 GMT 2023
|
PRIMARY | |||
|
Islatravir
Created by
admin on Sat Dec 16 10:11:50 GMT 2023 , Edited by admin on Sat Dec 16 10:11:50 GMT 2023
|
PRIMARY | |||
|
300000020771
Created by
admin on Sat Dec 16 10:11:50 GMT 2023 , Edited by admin on Sat Dec 16 10:11:50 GMT 2023
|
PRIMARY | |||
|
C174896
Created by
admin on Sat Dec 16 10:11:50 GMT 2023 , Edited by admin on Sat Dec 16 10:11:50 GMT 2023
|
PRIMARY | |||
|
EF-144
Created by
admin on Sat Dec 16 10:11:50 GMT 2023 , Edited by admin on Sat Dec 16 10:11:50 GMT 2023
|
PRIMARY | |||
|
DTXSID601046407
Created by
admin on Sat Dec 16 10:11:50 GMT 2023 , Edited by admin on Sat Dec 16 10:11:50 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
|
SOLVATE->ANHYDROUS |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
Unique mode of action byblocking primer translocation without causing direct chain termination.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
